(MEOH) Methanex - Overview
Exchange: NASDAQ •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA59151K1084
Stock: Methanol, Storage, Terminal
Total Rating 37
Risk 91
Buy Signal -0.14
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.96% |
| Yield on Cost 5y | 2.54% |
| Yield CAGR 5y | 22.84% |
| Payout Consistency | 93.9% |
| Payout Ratio | 33.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.2% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | -28.78 |
| Character TTM | |
|---|---|
| Beta | 1.464 |
| Beta Downside | 1.795 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.16% |
| CAGR/Max DD | -0.02 |
Description: MEOH Methanex January 13, 2026
Methanex Corp. (NASDAQ:MEOH) is the world’s largest dedicated methanol producer, operating facilities and a network of storage terminals across Asia-Pacific, North America, Europe, and South America. Incorporated in 1968 and headquartered in Vancouver, Canada, the company supplies methanol primarily to chemical and petrochemical manufacturers.
Key operational metrics (FY 2023) include roughly 10 million metric tons of methanol production capacity and an operating cash flow conversion of about 70 %, reflecting strong pricing power when natural-gas feedstock costs are low. The business is highly sensitive to natural-gas spot prices, which drive roughly 70 % of its production cost, and to downstream demand for formaldehyde, acetic acid, and MTBE-segments that historically account for over 80 % of methanol consumption. A growing sector catalyst is the emerging “green methanol” market, where renewable-hydrogen-based methanol is gaining traction as a low-carbon fuel and shipping bunkering option.
For a deeper, data-driven view of MEOH’s valuation dynamics, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 213.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 4.43 > 1.0 |
| NWC/Revenue: 22.05% < 20% (prev 11.43%; Δ 10.62% < -1%) |
| CFO/TA 0.12 > 3% & CFO 878.8m > Net Income 213.8m |
| Net Debt (3.20b) to EBITDA (945.6m): 3.38 < 3 |
| Current Ratio: 2.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.3m) vs 12m ago 14.57% < -2% |
| Gross Margin: 22.87% > 18% (prev 0.17%; Δ 2269 % > 0.5%) |
| Asset Turnover: 50.83% > 50% (prev 56.97%; Δ -6.14% > 0%) |
| Interest Coverage Ratio: 2.54 > 6 (EBITDA TTM 945.6m / Interest Expense TTM 211.6m) |
Altman Z'' 2.54
| A: 0.10 (Total Current Assets 1.51b - Total Current Liabilities 721.8m) / Total Assets 7.52b |
| B: 0.23 (Retained Earnings 1.76b / Total Assets 7.52b) |
| C: 0.08 (EBIT TTM 537.1m / Avg Total Assets 7.00b) |
| D: 0.55 (Book Value of Equity 2.57b / Total Liabilities 4.65b) |
| Altman-Z'' Score: 2.54 = A |
Beneish M -3.60
| DSRI: 0.67 (Receivables 441.6m/682.1m, Revenue 3.56b/3.69b) |
| GMI: 0.76 (GM 22.87% / 17.48%) |
| AQI: 1.04 (AQ_t 0.09 / AQ_t-1 0.09) |
| SGI: 0.96 (Revenue 3.56b / 3.69b) |
| TATA: -0.09 (NI 213.8m - CFO 878.8m) / TA 7.52b) |
| Beneish M-Score: -3.60 (Cap -4..+1) = AAA |
What is the price of MEOH shares?
As of February 08, 2026, the stock is trading at USD 47.23 with a total of 527,951 shares traded.
Over the past week, the price has changed by -1.03%, over one month by +7.07%, over three months by +31.82% and over the past year by -5.50%.
Over the past week, the price has changed by -1.03%, over one month by +7.07%, over three months by +31.82% and over the past year by -5.50%.
Is MEOH a buy, sell or hold?
Methanex has received a consensus analysts rating of 4.22.
Therefore, it is recommended to buy MEOH.
- StrongBuy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MEOH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.1 | 6.1% |
| Analysts Target Price | 50.1 | 6.1% |
| ValueRay Target Price | 48.1 | 1.9% |
MEOH Fundamental Data Overview February 02, 2026
P/E Trailing = 16.3986
P/E Forward = 15.8983
P/S = 1.034
P/B = 1.473
P/EG = 0.98
Revenue TTM = 3.56b USD
EBIT TTM = 537.1m USD
EBITDA TTM = 945.6m USD
Long Term Debt = 2.79b USD (from longTermDebt, last quarter)
Short Term Debt = 158.6m USD (from shortTermDebt, last quarter)
Debt = 3.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.20b USD (from netDebt column, last quarter)
Enterprise Value = 6.89b USD (3.69b + Debt 3.61b - CCE 413.0m)
Interest Coverage Ratio = 2.54 (Ebit TTM 537.1m / Interest Expense TTM 211.6m)
EV/FCF = 9.08x (Enterprise Value 6.89b / FCF TTM 758.8m)
FCF Yield = 11.01% (FCF TTM 758.8m / Enterprise Value 6.89b)
FCF Margin = 21.32% (FCF TTM 758.8m / Revenue TTM 3.56b)
Net Margin = 6.01% (Net Income TTM 213.8m / Revenue TTM 3.56b)
Gross Margin = 22.87% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.75b) / Revenue TTM)
Gross Margin QoQ = 7.38% (prev 27.07%)
Tobins Q-Ratio = 0.92 (Enterprise Value 6.89b / Total Assets 7.52b)
Interest Expense / Debt = 1.67% (Interest Expense 60.2m / Debt 3.61b)
Taxrate = 47.51% (3.75m / 7.90m)
NOPAT = 281.9m (EBIT 537.1m * (1 - 47.51%))
Current Ratio = 2.09 (Total Current Assets 1.51b / Total Current Liabilities 721.8m)
Debt / Equity = 1.41 (Debt 3.61b / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = 3.38 (Net Debt 3.20b / EBITDA 945.6m)
Debt / FCF = 4.21 (Net Debt 3.20b / FCF TTM 758.8m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.05% (Net Income 213.8m / Total Assets 7.52b)
RoE = 8.97% (Net Income TTM 213.8m / Total Stockholder Equity 2.38b)
RoCE = 10.38% (EBIT 537.1m / Capital Employed (Equity 2.38b + L.T.Debt 2.79b))
RoIC = 5.60% (NOPAT 281.9m / Invested Capital 5.04b)
WACC = 6.15% (E(3.69b)/V(7.30b) * Re(11.31%) + D(3.61b)/V(7.30b) * Rd(1.67%) * (1-Tc(0.48)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 6.98%
[DCF Debug] Terminal Value 83.96% ; FCFF base≈602.1m ; Y1≈535.1m ; Y5≈447.5m
Fair Price DCF = 120.6 (EV 12.52b - Net Debt 3.20b = Equity 9.33b / Shares 77.3m; r=6.15% [WACC]; 5y FCF grow -13.70% → 2.90% )
EPS Correlation: -43.84 | EPS CAGR: -59.86% | SUE: -1.91 | # QB: 0
Revenue Correlation: -79.95 | Revenue CAGR: -7.98% | SUE: -0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.90 | Chg30d=+0.075 | Revisions Net=-3 | Analysts=6
EPS next Year (2026-12-31): EPS=3.38 | Chg30d=+0.012 | Revisions Net=+2 | Growth EPS=+12.8% | Growth Revenue=+11.5%
P/E Forward = 15.8983
P/S = 1.034
P/B = 1.473
P/EG = 0.98
Revenue TTM = 3.56b USD
EBIT TTM = 537.1m USD
EBITDA TTM = 945.6m USD
Long Term Debt = 2.79b USD (from longTermDebt, last quarter)
Short Term Debt = 158.6m USD (from shortTermDebt, last quarter)
Debt = 3.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.20b USD (from netDebt column, last quarter)
Enterprise Value = 6.89b USD (3.69b + Debt 3.61b - CCE 413.0m)
Interest Coverage Ratio = 2.54 (Ebit TTM 537.1m / Interest Expense TTM 211.6m)
EV/FCF = 9.08x (Enterprise Value 6.89b / FCF TTM 758.8m)
FCF Yield = 11.01% (FCF TTM 758.8m / Enterprise Value 6.89b)
FCF Margin = 21.32% (FCF TTM 758.8m / Revenue TTM 3.56b)
Net Margin = 6.01% (Net Income TTM 213.8m / Revenue TTM 3.56b)
Gross Margin = 22.87% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.75b) / Revenue TTM)
Gross Margin QoQ = 7.38% (prev 27.07%)
Tobins Q-Ratio = 0.92 (Enterprise Value 6.89b / Total Assets 7.52b)
Interest Expense / Debt = 1.67% (Interest Expense 60.2m / Debt 3.61b)
Taxrate = 47.51% (3.75m / 7.90m)
NOPAT = 281.9m (EBIT 537.1m * (1 - 47.51%))
Current Ratio = 2.09 (Total Current Assets 1.51b / Total Current Liabilities 721.8m)
Debt / Equity = 1.41 (Debt 3.61b / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = 3.38 (Net Debt 3.20b / EBITDA 945.6m)
Debt / FCF = 4.21 (Net Debt 3.20b / FCF TTM 758.8m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.05% (Net Income 213.8m / Total Assets 7.52b)
RoE = 8.97% (Net Income TTM 213.8m / Total Stockholder Equity 2.38b)
RoCE = 10.38% (EBIT 537.1m / Capital Employed (Equity 2.38b + L.T.Debt 2.79b))
RoIC = 5.60% (NOPAT 281.9m / Invested Capital 5.04b)
WACC = 6.15% (E(3.69b)/V(7.30b) * Re(11.31%) + D(3.61b)/V(7.30b) * Rd(1.67%) * (1-Tc(0.48)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 6.98%
[DCF Debug] Terminal Value 83.96% ; FCFF base≈602.1m ; Y1≈535.1m ; Y5≈447.5m
Fair Price DCF = 120.6 (EV 12.52b - Net Debt 3.20b = Equity 9.33b / Shares 77.3m; r=6.15% [WACC]; 5y FCF grow -13.70% → 2.90% )
EPS Correlation: -43.84 | EPS CAGR: -59.86% | SUE: -1.91 | # QB: 0
Revenue Correlation: -79.95 | Revenue CAGR: -7.98% | SUE: -0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.90 | Chg30d=+0.075 | Revisions Net=-3 | Analysts=6
EPS next Year (2026-12-31): EPS=3.38 | Chg30d=+0.012 | Revisions Net=+2 | Growth EPS=+12.8% | Growth Revenue=+11.5%